DarioHealth Corp. Common Stock (DRIO) is a publicly traded Healthcare sector company. As of May 21, 2026, DRIO trades at $8.13 with a market cap of $61.06M and a P/E ratio of 1.46. DRIO moved -2.44% today. Year to date, DRIO is -23.95%; over the trailing twelve months it is -39.39%. Its 52-week range spans $5.94 to $31.00. Analyst consensus is buy with an average price target of $10.50. Rallies surfaces DRIO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
DRIO financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. DRIO recently traded at $8.13. Market cap is $61.06M. P/E ratio is 1.46. Revenue is $21.19M.
| Metric | Value |
|---|---|
| Price | $8.13 |
| Market Cap | $61.06M |
| P/E Ratio | 1.46 |
| EPS | $5.46 |
| Dividend Yield | 0.00% |
| 52-Week High | $31.00 |
| 52-Week Low | $5.94 |
| Volume | 20 |
| Avg Volume | 0 |
| Revenue (TTM) | $21.19M |
| Net Income | $-40.74M |
| Gross Margin | 56.55% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $22.36M | $-41.71M | $10.12 |
| 2024 | $27.04M | $-42.75M | $0.61 |
| 2023 | $20.35M | $-59.43M | $1.93 |
| 2022 | $27.66M | $-62.19M | $2.54 |
2 analysts cover DRIO: 0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $10.50.